Finally, the study found that upregulating mutations in YTHDF1 and HNRNPA2B1 correlated with tumor stage and treatment response in patients, further supporting their roles, asm6A regulatory genes, in melanoma. The gene discussed is YTHDF1; the disease is neoplasm.